Revvity Inc vs Xpeng Inc - ADR — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while Xpeng Inc - ADR trades at $13.38 (market cap $12.96B). The key difference: Revvity Inc and Xpeng Inc - ADR are close in size by market cap, and Revvity Inc pays a 0.26% dividend while Xpeng Inc - ADR pays none. Which is the better fit depends on your goals.
| RVTY | XPEV | |
|---|---|---|
Market Cap | $11.87B | $12.96B |
Sector | Technology | Consumer Cyclical |
52-Week High | $117.75 | $28.07 |
52-Week Low | $82.26 | $12.09 |
Enterprise Value | $14.36B | $15.07B |
Dividend Yield | 0.26% | — |
Trailing returns across standard periods
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →Founded in 2015, XPeng is a leading Chinese smart electric vehicle, or EV, company that designs, develops, manufactures and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 98,000 EVs in 2021, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
Read more on XPEV →